Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1983 Mar;110(3):290-6.

Aggregation of equine platelets by Onchocerca cervicalis collagen

Aggregation of equine platelets by Onchocerca cervicalis collagen

L A McConnell et al. Am J Pathol. 1983 Mar.

Abstract

The arachidonic acid pathway plays an important role in many inflammatory reactions. Current evidence suggests that platelets can play a central part in host inflammation. Since microfilariae are mobilized into the bloodstream following diethylcarbamazine (DEC) treatment, we have studied the effects of Onchocerca cervicalis cuticle preparations on equine platelet aggregation. The authors have found that O cervicalis cuticular preparations can induce platelet aggregation in vitro. Furthermore, this activity was abrogated by treatment with collagenase and not hyaluronidase, elastase, or alpha-chymotrypsin. When this evidence is viewed collectively with the evidence for in vivo parasite cuticular damage following DEC treatment, it becomes entirely plausible that the cuticular damage may indeed reveal a platelet-reactive surface, thus permitting platelet-parasite binding to occur. This binding would result in platelet aggregation and the generation and release of platelet-derived arachidonate metabolites. These metabolites may play a very critical role in the development of the described pathologic sequelae observed following DEC treatment. Field studies using cyclooxygenase and lipoxygenase inhibitors might therefore be very efficacious in decreasing the frequency of side effects due to DEC or other potentially effective drug regimens.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Lancet. 1967 Sep 2;2(7514):495-7 - PubMed
    1. Lancet. 1968 Apr 13;1(7546):779-83 - PubMed
    1. Proc Soc Exp Biol Med. 1968 Feb;127(2):547-51 - PubMed
    1. J Clin Invest. 1968 Dec;47(12):2616-21 - PubMed
    1. Trans R Soc Trop Med Hyg. 1969;63(4):548 - PubMed

Publication types

LinkOut - more resources